Influence of Elastin-Like Polypeptide and Hydrophobin on Recombinant Hemagglutinin Accumulations in Transgenic Tobacco Plants

Fusion protein strategies are useful tools to enhance expression and to support the development of purification technologies. The capacity of fusion protein strategies to enhance expression was explored in tobacco leaves and seeds. C-terminal fusion of elastin-like polypeptides (ELP) to influenza hemagglutinin under the control of either the constitutive CaMV 35S or the seed-specific USP promoter resulted in increased accumulation in both leaves and seeds compared to the unfused hemagglutinin. The addition of a hydrophobin to the C-terminal end of hemagglutinin did not significantly increase the expression level. We show here that, depending on the target protein, both hydrophobin fusion and ELPylation combined with endoplasmic reticulum (ER) targeting induced protein bodies in leaves as well as in seeds. The N-glycosylation pattern indicated that KDEL sequence-mediated retention of leaf-derived hemagglutinins and hemagglutinin-hydrophobin fusions were not completely retained in the ER. In contrast, hemagglutinin-ELP from leaves contained only the oligomannose form, suggesting complete ER retention. In seeds, ER retention seems to be nearly complete for all three constructs. An easy and scalable purification method for ELPylated proteins using membrane-based inverse transition cycling could be applied to both leaf- and seed-expressed hemagglutinins.

[1]  T. M. Parker,et al.  Biocompatibility of the Bioelastic Materials, Poly(GVGVP) and Its γ-Irradiation Cross-Linked Matrix: Summary of Generic Biological Test Results , 1991 .

[2]  A. Chilkoti,et al.  Purification of recombinant proteins from Escherichia coli at low expression levels by inverse transition cycling. , 2007, Analytical biochemistry.

[3]  M. Veit,et al.  Association of Influenza Virus Proteins with Membrane Rafts , 2011, Advances in virology.

[4]  Gerd Hause,et al.  ELPylated haemagglutinins produced in tobacco plants induce potentially neutralizing antibodies against H5N1 viruses in mice. , 2013, Plant biotechnology journal.

[5]  S. Schmidt,et al.  Fusion protein technologies for biopharmaceuticals : applications and challenges , 2013 .

[6]  T. Higgins,et al.  Vicilin with carboxy-terminal KDEL is retained in the endoplasmic reticulum and accumulates to high levels in the leaves of transgenic plants. , 1992, The Plant journal : for cell and molecular biology.

[7]  U. Conrad,et al.  Membrane-Based Inverse Transition Cycling: An Improved Means for Purifying Plant-Derived Recombinant Protein-Elastin-Like Polypeptide Fusions , 2011, International journal of molecular sciences.

[8]  C. Xiang,et al.  A mini binary vector series for plant transformation , 1999, Plant Molecular Biology.

[9]  P. Rottier,et al.  A Single Immunization with Soluble Recombinant Trimeric Hemagglutinin Protects Chickens against Highly Pathogenic Avian Influenza Virus H5N1 , 2010, PloS one.

[10]  Stefan Rose-John,et al.  Elastin-like polypeptides revolutionize recombinant protein expression and their biomedical application. , 2010, Trends in biotechnology.

[11]  R. Evangelista,et al.  Process and Economic Evaluation of the Extraction and Purification of Recombinant β‐Glucuronidase from Transgenic Corn , 1998, Biotechnology progress.

[12]  H. Klenk,et al.  Carbohydrates of influenza virus. Structural elucidation of the individual glycans of the FPV hemagglutinin by two‐dimensional 1H n.m.r. and methylation analysis. , 1985, The EMBO journal.

[13]  S. Schillberg,et al.  Molecular farming : plant-made pharmaceuticals and technical proteins , 2004 .

[14]  A. Davoodi-Semiromi,et al.  The green vaccine: A global strategy to combat infectious and autoimmune diseases , 2009, Human vaccines.

[15]  T. Thannhauser,et al.  Comparative characterization of the glycosylation profiles of an influenza hemagglutinin produced in plant and insect hosts , 2012, Proteomics.

[16]  I. Llop-Tous,et al.  Protein body induction: a new tool to produce and recover recombinant proteins in plants. , 2009, Methods in molecular biology.

[17]  U. Bonas,et al.  New type III effectors from Xanthomonas campestris pv. vesicatoria trigger plant reactions dependent on a conserved N-myristoylation motif. , 2007, Molecular plant-microbe interactions : MPMI.

[18]  J. Scheller,et al.  Functional expression of a biologically active fragment of soluble gp130 as an ELP-fusion protein in transgenic plants: purification via inverse transition cycling. , 2006, The Biochemical journal.

[19]  J. Scheller,et al.  Influence of elastin-like peptide fusions on the quantity and quality of a tobacco-derived human immunodeficiency virus-neutralizing antibody. , 2009, Plant biotechnology journal.

[20]  R. Menassa,et al.  Elastin-like polypeptide fusions enhance the accumulation of recombinant proteins in tobacco leaves , 2007, Transgenic Research.

[21]  Ashutosh Chilkoti,et al.  Purification of recombinant proteins by fusion with thermally-responsive polypeptides , 1999, Nature Biotechnology.

[22]  W. Gerhard The role of the antibody response in influenza virus infection. , 2001, Current topics in microbiology and immunology.

[23]  S. Munro,et al.  A C-terminal signal prevents secretion of luminal ER proteins , 1987, Cell.

[24]  Brian J. Ward,et al.  Preclinical and Clinical Development of Plant-Made Virus-Like Particle Vaccine against Avian H5N1 Influenza , 2010, PloS one.

[25]  U. Conrad,et al.  Expression of Complete Antibodies in Transgenic Plants , 2010 .

[26]  P. Christou,et al.  Sowing the seeds of success: pharmaceutical proteins from plants. , 2005, Current opinion in biotechnology.

[27]  P. Heifetz,et al.  Eukaryotic protein production in designed storage organelles , 2009, BMC Biology.

[28]  U. Conrad,et al.  Immunomodulation of plant function by in vitro selected single-chain Fv intrabodies. , 2009, Methods in molecular biology.

[29]  Brian J Ward,et al.  Influenza virus-like particles produced by transient expression in Nicotiana benthamiana induce a protective immune response against a lethal viral challenge in mice. , 2008, Plant biotechnology journal.

[30]  M. Penttilä,et al.  Genetic and biochemical characterization of the Trichoderma reesei hydrophobin HFBI. , 1996, European journal of biochemistry.

[31]  E. Rybicki,et al.  Expression in tobacco and purification of beak and feather disease virus capsid protein fused to elastin-like polypeptides. , 2013, Journal of virological methods.

[32]  F. Altmann,et al.  N-Glycan analysis by matrix-assisted laser desorption/ionization mass spectrometry of electrophoretically separated nonmammalian proteins: application to peanut allergen Ara h 1 and olive pollen allergen Ole e 1. , 2000, Analytical biochemistry.

[33]  J. Scheller,et al.  Purification of Spider Silk-elastin from Transgenic Plants and Application for Human Chondrocyte Proliferation , 2004, Transgenic Research.

[34]  K. Musiychuk,et al.  A plant‐based system for rapid production of influenza vaccine antigens , 2011, Influenza and other respiratory viruses.

[35]  R. Herrero-Vanrell,et al.  Biocompatibility of elastin-like polymer poly(VPAVG) microparticles: in vitro and in vivo studies. , 2006, Journal of biomedical materials research. Part A.

[36]  Carole Plasson,et al.  Plant-specific glycosylation patterns in the context of therapeutic protein production. , 2010, Plant biotechnology journal.

[37]  A. Conley,et al.  Induction of protein body formation in plant leaves by elastin-like polypeptide fusions , 2009 .

[38]  Sulaiman Mohd Roslan,et al.  実験動物におけるMelicope ptelefoliaエタノール抽出物の鎮痛作用 | 文献情報 | J-GLOBAL 科学技術総合リンクセンター , 2010 .

[39]  J. Scheller,et al.  ELP‐Fusion Technology for Biopharmaceuticals , 2013 .

[40]  M. Sharma,et al.  Plants as bioreactors: Recent developments and emerging opportunities , 2009, Biotechnology Advances.

[41]  J. Scheller,et al.  Biochemical and functional characterization of anti-HIV antibody-ELP fusion proteins from transgenic plants. , 2008, Plant biotechnology journal.

[42]  Rima Menassa,et al.  Optimization of elastin‐like polypeptide fusions for expression and purification of recombinant proteins in plants , 2009, Biotechnology and bioengineering.

[43]  M. Penttilä,et al.  Efficient purification of recombinant proteins using hydrophobins as tags in surfactant-based two-phase systems. , 2004, Biochemistry.

[44]  Yohei Watanabe,et al.  The changing nature of avian influenza A virus (H5N1). , 2012, Trends in microbiology.

[45]  J. Howard,et al.  Overproduction of recombinant proteins in plants. , 2012, Plant science : an international journal of experimental plant biology.

[46]  P. Christou,et al.  Unexpected Deposition Patterns of Recombinant Proteins in Post-Endoplasmic Reticulum Compartments of Wheat Endosperm1 , 2004, Plant Physiology.

[47]  M. Linder,et al.  Hydrophobin Fusions for High-Level Transient Protein Expression and Purification in Nicotiana benthamiana1[W][OA] , 2009, Plant Physiology.

[48]  Rima Menassa,et al.  Protein body formation in stable transgenic tobacco expressing elastin-like polypeptide and hydrophobin fusion proteins , 2013, BMC Biotechnology.

[49]  V. Yusibov,et al.  Recent progress in the development of plant derived vaccines , 2008, Expert review of vaccines.

[50]  R. Frutos,et al.  Expression and Immunogenicity of the Mycobacterial Ag85B/ESAT-6 Antigens Produced in Transgenic Plants by Elastin-Like Peptide Fusion Strategy , 2010, Journal of biomedicine & biotechnology.

[51]  A. Conley,et al.  Expression and purification of an anti-Foot-and-mouth disease virus single chain variable antibody fragment in tobacco plants , 2009, Transgenic Research.

[52]  J. Fry,et al.  A simple and general method for transferring genes into plants. , 1985, Science.

[53]  A. Chilkoti,et al.  Purification of an elastin‐like fusion protein by microfiltration , 2006, Biotechnology and bioengineering.

[54]  S. Isayenkov,et al.  Suppression of Allene Oxide Cyclase in Hairy Roots of Medicago truncatula Reduces Jasmonate Levels and the Degree of Mycorrhization with Glomus intraradices1[w] , 2005, Plant Physiology.

[55]  Wei Shi,et al.  Comparative Efficacy of Neutralizing Antibodies Elicited by Recombinant Hemagglutinin Proteins from Avian H5N1 Influenza Virus , 2008, Journal of Virology.

[56]  J. Scheller,et al.  ELPylated anti-human TNF therapeutic single-domain antibodies for prevention of lethal septic shock. , 2011, Plant biotechnology journal.